Cargando…
Assessment of the effect of potential antifibrotic compounds on total and αVβ6 integrin‐mediated TGF‐β activation
Transforming growth factor‐β (TGF‐β) plays an important role in the development of tissue fibrosis, and molecules inhibiting this pathway are attractive therapeutic targets for fibrotic diseases such as idiopathic pulmonary fibrosis (IPF). Activation of TGF‐β is the rate‐limiting step in TGF‐β bioav...
Autores principales: | Porte, Joanne, Jenkins, Gisli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186436/ https://www.ncbi.nlm.nih.gov/pubmed/25505594 http://dx.doi.org/10.1002/prp2.30 |
Ejemplares similares
-
Goldilocks and the Three Trials: Clinical Trials Targeting the α(v)β(6) Integrin in Idiopathic Pulmonary Fibrosis
por: Sime, Patricia, et al.
Publicado: (2022) -
TGFβ(1 )signaling via α(V)β(6 )integrin
por: Kracklauer, Martin P, et al.
Publicado: (2003) -
Integrin α(V)β(6)-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1
por: Annes, Justin P., et al.
Publicado: (2004) -
Inhibition of Integrin αvβ6 Activation of TGF‐β Attenuates Tendinopathy
por: Wang, Xiao, et al.
Publicado: (2022) -
Nintedanib-Containing Dual Conjugates Targeting α(V)β(6) Integrin and Tyrosine Kinase Receptors
as Potential Antifibrotic Agents
por: Bugatti, Kelly, et al.
Publicado: (2022)